Status: Recruiting
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
This is a Phase 1 study to assess the safety of ERX-315 in patients with advanced solid tumors that have failed approved systemic therapies.
Participants needed: 36
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: EtiraRx Australia Pty LtdUpdated: May 29, 2026Locations: 5
Eligibility criteria
Patients must be at least 18 years of age at the time of signing the informed co... [+5]
Systemic anti cancer therapy within 4 weeks of first dose of study drug [+3]